Skip to content
Ironwood Pharmaceuticals
Ironwood Pharmaceuticals
  • Investors & Media
  • Contact Us
  • Investors & Media
  • Contact Us
Ironwood Pharmaceuticals Logo
Ironwood Pharmaceuticals
Close
  • Company
    • Company Overview
    • Leadership
    • Open Payments & Transparency
  • Science & Medicine
    • Therapeutic Focus
    • Pipeline
    • Product
  • Patients
    • Overview
  • Responsibility
    • Overview
    • Diversity, Equity & Inclusion
    • Sustainability
    • Safety & Compliance
    • Patients & Research
    • Community Giving
  • Careers
    • Working at Ironwood
    • Internships, Co-ops
      and Fellowships
    • Open Positions
  • Company
    • Company Overview
    • Leadership
    • Open Payments & Transparency
  • Science & Medicine
    • Therapeutic Focus
    • Pipeline
    • Product
  • Patients
    • Overview
  • Responsibility
    • Overview
    • Diversity, Equity & Inclusion
    • Sustainability
    • Safety & Compliance
    • Patients & Research
    • Community Giving
  • Careers
    • Working at Ironwood
    • Internships, Co-ops
      and Fellowships
    • Open Positions

Year: 2018

Ironwood Pharmaceuticals to Present at 27th Annual Credit Suisse Healthcare Conference

https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-to-Present-at-27th-Annual-Credit-Suisse-Healthcare-Conference/default.aspx

Ironwood Pharmaceuticals to Present at 27th Annual Credit Suisse Healthcare Conference

https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-to-Present-at-27th-Annual-Credit-Suisse-Healthcare-Conference/default.aspx

Ironwood Pharmaceuticals Provides Third Quarter 2018 Investor Update

https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-Provides-Third-Quarter-2018-Investor-Update/default.aspx

Ironwood Pharmaceuticals Provides Third Quarter 2018 Investor Update

https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-Provides-Third-Quarter-2018-Investor-Update/default.aspx

Ironwood Pharmaceuticals to Host Third Quarter 2018 Investor Update Call

https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-to-Host-Third-Quarter-2018-Investor-Update-Call/default.aspx

Ironwood Pharmaceuticals to Host Third Quarter 2018 Investor Update Call

https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-to-Host-Third-Quarter-2018-Investor-Update-Call/default.aspx

Ironwood Pharmaceuticals Presenting IW-3718 and Linaclotide Data at the American College of Gastroenterology 2018 Annual Scientific Meeting

https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-Presenting-IW-3718-and-Linaclotide-Data-at-the-American-College-of-Gastroenterology-2018-Annual-Scientific-Meeting/default.aspx

Ironwood Pharmaceuticals Presenting IW-3718 and Linaclotide Data at the American College of Gastroenterology 2018 Annual Scientific Meeting

https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-Presenting-IW-3718-and-Linaclotide-Data-at-the-American-College-of-Gastroenterology-2018-Annual-Scientific-Meeting/default.aspx

Ironwood Pharmaceuticals Announces FDA Fast Track Designation for Praliciguat for the Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF)

https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-Announces-FDA-Fast-Track-Designation-for-Praliciguat-for-the-Treatment-of-Heart-Failure-with-Preserved-Ejection-Fraction-HFpEF/default.aspx

Ironwood Pharmaceuticals Announces FDA Fast Track Designation for Praliciguat for the Treatment of Heart Failure with Preserved Ejection Fraction (HFpEF)

https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Pharmaceuticals-Announces-FDA-Fast-Track-Designation-for-Praliciguat-for-the-Treatment-of-Heart-Failure-with-Preserved-Ejection-Fraction-HFpEF/default.aspx

Next →
Ironwood Pharmaceuticals Home
  • Investors & Media
  • Contact Us
Linkedin Twitter
  • Company
    • Company Overview
    • Leadership
    • Open Payments & Transparency
  • Science & Medicine
    • Therapeutic Focus
    • Pipeline
    • Product
  • Patients
    • Overview
  • Responsibility
    • Overview
    • Diversity, Equity & Inclusion
    • Sustainability
    • Safety & Compliance
    • Patients & Research
    • Community Giving
  • Careers
    • Working at Ironwood
    • Internships, Co-ops
      and Fellowships
    • Open Positions
  • Copyright © 2024 Ironwood. All rights reserved
  • Privacy Policy
  • Terms of Use
  • Company
    • Company Overview
    • Leadership
    • Open Payments & Transparency
  • Science & Medicine
    • Therapeutic Focus
    • Pipeline
    • Product
  • Patients
    • Overview
  • Responsibility
    • Overview
    • Diversity, Equity & Inclusion
    • Sustainability
    • Safety & Compliance
    • Patients & Research
    • Community Giving
  • Careers
    • Working at Ironwood
    • Internships, Co-ops
      and Fellowships
    • Open Positions
    • Investors & Media
    • Contact Us